Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial

NCT01370733 is registered in ClinicalTrials.gov with Wave Neuroscience as lead sponsor.

NCT NCT01370733
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01370733 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Low Emission NeoSync EEG Synchronized TMS Technology for the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Sham-Controlled, Trial
Lead sponsor
Wave Neuroscience
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2012
Completion date
September 30, 2013
Enrollment
202 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder